Efficacy and Safety of Abacavir Plus Lamivudine Versus Didanosine Plus Stavudine When Combined with a Protease Inhibitor, a Nonnucleoside Reverse Transcriptase Inhibitor, or Both in HIV-1 Positive Antiretroviral-Naive Persons

Hiv 1

Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0000000000002153 ◽

2019 ◽

Vol 82 (4) ◽

pp. e47-e49 ◽

Cited By ~ 4

Author(s):

Alexander Wong ◽

Deborah Goldstein ◽

Josep Mallolas ◽

Edwin DeJesus ◽

Margaret Johnson ◽

...

Keyword(s):

Reverse Transcriptase ◽

Tenofovir Disoproxil Fumarate ◽

Transcriptase Inhibitor ◽

Efficacy And Safety ◽

Resistance Mutations ◽

Treatment Naïve ◽

Inhibitor Resistance ◽

Hiv 1

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

AIDS ◽

10.1097/qad.0b013e328328f789 ◽

2009 ◽

Vol 27 (7) ◽

pp. 817-824 ◽

Cited By ~ 171

Author(s):

Claudine Duvivier ◽

Sami Kolta ◽

Lambert Assoumou ◽

Jade Ghosn ◽

Sylvie Rozenberg ◽

...

Keyword(s):

Bone Mineral Density ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Bone Mineral ◽

Transcriptase Inhibitor ◽

Mineral Density ◽

Hiv 1

Protease Inhibitor and Nonnucleoside Reverse Transcriptase Inhibitor Concentrations in the Genital Tract of HIV-1-Infected Women

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/00126334-200412150-00008 ◽

2004 ◽

Vol 37 (5) ◽

pp. 1577-1580 ◽

Cited By ~ 35

Author(s):

Sherene S. Min ◽

Amanda H. Corbett ◽

Naser Rezk ◽

Susan Cu-Uvin ◽

Susan A. Fiscus ◽

...

Keyword(s):

Protease Inhibitor ◽

Reverse Transcriptase ◽

Genital Tract ◽

Transcriptase Inhibitor ◽

Hiv 1

Initial highly-active antiretroviral therapy with a protease inhibitor versus a nonnucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect metaanalyses

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70040-3 ◽

2007 ◽

Vol 2007 ◽

pp. 61-62

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Highly Active Antiretroviral Therapy ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Reverse Transcriptase Inhibitor

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing nonnucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: openlabel randomised trial

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70039-7 ◽

2007 ◽

Vol 2007 ◽

pp. 60-61

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Randomised Trial ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection

AIDS ◽

10.1097/00002030-199814000-00015 ◽

1998 ◽

Vol 12 (14) ◽

pp. 1833-1844 ◽

Cited By ~ 53

Author(s):

Janis V. Giorgi ◽

Martin A. Majchrowicz ◽

Timothy D. Johnson ◽

Patricia Hultin ◽

Jose Matud ◽

...

Keyword(s):

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Inhibitor Therapy ◽

Previously Treated ◽

Hiv 1

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkq432 ◽

2010 ◽

Vol 66 (2) ◽

pp. 358-362 ◽

Cited By ~ 14

Author(s):

A. Imaz ◽

J. M. Llibre ◽

M. Mora ◽

G. Mateo ◽

A. Camacho ◽

...

Keyword(s):

Reverse Transcriptase ◽

Salvage Therapy ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Multidrug Resistant ◽

Efficacy And Safety ◽

New Class ◽

New Generation ◽

Hiv 1

Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission

AIDS ◽

10.1097/qad.0000000000001816 ◽

2018 ◽

Vol 32 (12) ◽

pp. 1625-1632

Author(s):

Rose Masaba ◽

Craig B. Borkowf ◽

Sonali Girde ◽

Clement Zeh ◽

Richard Ndivo ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Mother To Child Transmission ◽

Child Transmission ◽

Infant Outcomes ◽

Mother To Child

Efficacy and Safety of Lersivirine Versus Etravirine for the Treatment of HIV-1 Infection in Patients with Prior Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Use and Evidence of NNRTI Resistance: A Randomized Phase 2B Trial

HIV Clinical Trials ◽

10.1310/hct1505-209 ◽

2014 ◽

Vol 15 (5) ◽

pp. 209-217 ◽

Cited By ~ 1

Author(s):

Edwin DeJesus ◽

Gerd Fätkenheuer ◽

Catherine Orrell ◽

Cunshan Wang ◽

James Jones ◽

...

Keyword(s):

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Efficacy And Safety ◽

Nnrti Resistance ◽

Hiv 1

Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227*

HIV Medicine ◽

10.1111/j.1468-1293.2008.00644.x ◽

2008 ◽

Cited By ~ 4

Author(s):

K Ruxrungtham ◽

RJ Pedro ◽

GH Latiff ◽

F Conradie ◽

P Domingo ◽

...

Keyword(s):

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitors ◽

Nucleoside Reverse Transcriptase Inhibitors ◽

Reverse Transcriptase Inhibitor